{"id":12326,"date":"2024-10-11T23:21:06","date_gmt":"2024-10-11T21:21:06","guid":{"rendered":"https:\/\/valintermed.com\/?p=12326"},"modified":"2024-10-11T23:21:06","modified_gmt":"2024-10-11T21:21:06","slug":"okulofaringealnaya-myshechnaya-distrofiya","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/oculofaringeal-myocardial-dystrophy\/","title":{"rendered":"Oculopharyngeal muscular dystrophy"},"content":{"rendered":"
<\/div>\n

Oculopharyngeal muscular dystrophy (OPMD) is a rare genetic disorder characterized by progressive weakness and atrophy of the eye and pharyngeal muscles. The disorder belongs to a group of dystrophies caused by dysfunction of skeletal muscles, which leads to decreased muscle strength. The main symptoms of OPMD include drooping of the upper eyelids (ptosis), difficulty swallowing (dysphagia), and karmic disorders - changes in eye movement and problems with articulation. The main symptoms appear in adulthood, usually after 50 years, but there are also cases of earlier onset of the disease. OPMD is hereditary in nature, associated with mutations in the genes responsible for myofibrillar structures. An important feature of this condition is its steady progression, which requires a comprehensive approach to diagnosis and treatment.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n